Capstan Medical is an innovative company revolutionizing the treatment of structural heart diseases, particularly focusing on mitral and tricuspid valve conditions. Established in 2020 at the Santa Cruz-based Occam Labs incubator, Capstan Medical integrates surgical robotics, catheter-based technology, and next-generation implants to create minimally invasive solutions for heart valve repairs and replacements. This approach aims to reduce recovery times and complications compared to traditional open-heart surgeries.

The company’s flagship platform treats heart valve conditions while the heart is still beating, leveraging advancements in medical robotics to ensure precision and improved patient outcomes. Their work addresses critical unmet needs, particularly in the absence of FDA-approved minimally invasive solutions for mitral and tricuspid valves, even as such technologies have transformed care for aortic valves.